SlideShare a Scribd company logo
Jornada de Microbiota Intestinal
Implicaciones en la Salud y Enfermedad
Madrid, 23 de octubre de 2017
Guarner & Malagelada, Lancet 2003
http://www.hmdb.ca
Fluid Total
Microbial
origin
% Microbial origin
All fluids 3821 129 3,4
Blood 2273 102 4,5
Urine 1741 101 5,8
Saliva 1233 59 4,8
CSF 440 36 8,2
Number of Metabolites Detected in Human Fluids
ILEO-CECAL DYSBIOSIS IN CHRONIC LIVER DISEASE
Guarner C & Runyon BA. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J
Hepatol 1997
Pardo A, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis.
Hepatology 2000
Francés R, et al. Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration
in rats with cirrhosis and ascites. J Hepatol 2007
SERUM MICROBIOME IN CHRONIC LIVER DISEASE
Santiago et al. Scientific Reports 2016
MICROBIOTA-INDUCED PROGRESSION TO CHRONIC LIVER DISEASE
Schnabl & Brenner, Gastroenterology 2015
Decision making in the adaptive (acquired) immune system is
instructed by the microbial impact on APCs and T cells
CD4
TCR
APC
CD4
Th1, Th17
Treg
Foxp3+
Th2
TNF-, IFN- IL-17
IL-10
IL-4, IL-5, IL-13
CD4
CD4
+
–
–
–
–
PRR
Foreign antigen
(Ag)
Naive T-cell
activation
Cytokines
+
TGF-b
Signatures via pattern
recognition receptors
(PRRs): TLRs & NLRs
(NOD+LRR)
Ligation
MHC II
T
+
By Per Brandtzaeg in Guarner et al, Nature Clin Practice 2006
F
F
FAE
Gut-Associated Lymphoid Tissue structures are strategically situated in relation to the
greatest concentration of microbiota
• Peyer’s patches:
distal ileum (nos. 100-250)
• Isolated lymphoid follicles (ILFs):
large bowel (nos. ~ 30 000)
Brandtzaeg, Immunological Investigations 2010
HUMAN BLOOD REGULATORY CELLS INDUCED BY
Faecalibacterium prausnitzii
Sarrabayrouse et al, PLoS Biol 2014
Commensal microbiota affects ischemic stroke outcome
Benakis et al, Nat Med 2016
Anticancer Immunotherapy and Microbiota
Vetizou et al, Science 2015
Anticancer immunotherapy and microbiota
Vetizou et al, Science 2015
THE ENEMY IS WITHIN THE FAECAL STREAM
Rutgeerts P, Goboes K, Peeters M, Hiele M, Penninckx F, Aerts R, Kerremans R,
Vantrappen G.
Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal
ileum. Lancet 1991;338:771-4.
Winslet MC, Allan A, Poxon V, Youngs D, Keighley MR.
Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the
inflammatory process. Gut 1994;35:236-42.
D’Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P.
Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in
excluded ileum. Gastroenterology 1998;114:262–267.
Immuno-
suppression
Drug
Mucosal
healing
Mild
Aminosalicylate
Budesonide
Low
Moderate
Azathioprine
Methotrexate
Corticosteroids
Medium
Strong
Anti-TNF
Anti-integrins
High
Mucosal lesions are caused by an aggressive immune response against
gut bacteria
Adapted from Holtmann et al. Z Gastroenterol 2002
Cell detachment
Macrophage
TNF-
TNF-
Severe tissue injury by inflammation: role of TNF-
enderetal,JImmunol1998
Modern life style Traditional lifestye
Birth in the hospital; increasing rate of caesarean delivery Vaginal delivery at home
Small family size Large family size, crowding
Life on concrete Life in contact with soil microorganisms
Sanitation of living spaces: environment colonized by
resistant micro-organisms (including resistant bacteria,
fungii, acari)
Ancestral colonization of the living environment
Antibiotic usage early in life No antibiotics in infant life
Daily body wash with hot water and soap Limited access to hot water and soap
Low rate of H. pylori colonization High rate of H. pylori colonization
Decline in endemic parasitism Common carriage of parasitic worms
Food conserved by refrigeration Food conserved by microbial fermentation
Consumption of processed foods Consumption of natural foods
IBD risk factors are linked with altered microbial colonization
Manichanh et al, Nature Reviews Gastroenterology 2012
Blaser & Falkow, Nature Rev Microbiol 2009
Clemente et al, Science Advances 2015
Clemente et al, Science Advances 2015
Manichanh et al, Nat Rev GH 2012
Profiling the Human Microbiome
Dysbiosis in IBD
Pascal et al, Gut 2017
Meta-Genomic Species
Nielsen et al, Nature Biotechnology 2014
Gene Richness and Species Diversity
Nielsen et al, Nature Biotechnology 2014
• Richness is greatly altered in Crohn’s
Disease
•* • *
•Gene Count •Species count
•Genes,N°
•MGS,N°
•050000010000001500000
•0100200300400
500
•p = 4.3e-10 (wilcox. test) • p = 4.9e-9 (wilcox. test)
•Healthy, n = 52 •CD, n = 73 •Healthy, n = 52 •CD, n = 73
•24
Richness is less altered in Ulcerative Colitis
*
MGS,N°
Genes,N°
p = 0.15 (wilcox. test)
Gene Count Species count
p = 0.019 (wilcox. test)
Healthy, n = 56 Healthy, n = 56UC, n = 65 UC, n = 65
2000006000001000000
100200300400500
•25Maziers et al, IHMC 2016
•26
Strong Species signal in CD Healthy, n = 52 CD, n = 73
Healthy
CD
Richness
Numerous Faecalibacterium spp
Maziers et al, IHMC 2016
Less strong Species signal associated with UC Healthy, n = 28 HR, n = 28 UC -1, n = 34 UC-2, n = 31
Healthy
UC
Richness •27
Maziers et al, IHMC 2016
• Reduction of SCFA producing bacteria (butyrate producers such as
Faecalibacterium, Roseburia, Lachnospiraceae, Eubacterium, Subdoligranulum).
• Increased mucus degradation potential by abnormal mucin degraders that
displace Akkermansia.
• Reduced hydrogen and methane production potential combined with increased
hydrogen sulphide formation potential. Hydrogen sulphide is toxic for the
epithelium.
• Increase in abundance of bacteria with LPS endotoxins (Proteobacteria) that
can drive inflammation.
• Increased potential to manage oxidative stress, i.e. microbes become able to
proliferate in close vicinity to the epithelium.
Conclusiones
• En pacientes con EII, hay una distorsión permanente del ecosistema microbiano
intestinal, incluso durante períodos de remisión, caracterizada por reducción de
riqueza de genes microbianos, reducción de la diversidad de especies e
inestabilidad de la comunidad.
• CD y UC tienen firmas microbianas distintas a nivel taxonómico, pero las
alteraciones funcionales son parecidas.
• Los cambios son más intensos en pacientes con CD, mientras que los pacientes
UC presentan mejor recuperación durante los períodos de remisión.
Acknowledgments
MetaHIT
Consortium
HUVH: V. Robles, N. Borruel, F. Casellas,
F. Guarner
INRA: E. Le Chatelier, N. Maziers, D.
Ehrlich
La Fe (Valencia) : B. Beltrán, P. Nos
Parc Tauli (Sabadell) : A. Villoria, X. Calvet

More Related Content

What's hot

Gut Reaction Synthesis 2015
Gut Reaction Synthesis 2015Gut Reaction Synthesis 2015
Gut Reaction Synthesis 2015
Josh Baxt
 
Charles poster_TK-1
Charles poster_TK-1Charles poster_TK-1
Charles poster_TK-1
Charles Okechukwu
 
Seminario biologia molecular
Seminario biologia molecularSeminario biologia molecular
Seminario biologia molecular
CarlaVegaSalazar
 
Statins Talk 2009
Statins Talk 2009Statins Talk 2009
Statins Talk 2009
rhondagarza
 
The gut in critical Illness: A perspective in five acts by Prof. John Marshall
The gut in critical Illness: A perspective in five acts by Prof. John MarshallThe gut in critical Illness: A perspective in five acts by Prof. John Marshall
The gut in critical Illness: A perspective in five acts by Prof. John Marshall
SMACC Conference
 
BRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicine
BRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicineBRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicine
BRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicine
brnmomentum
 
Nature10213
Nature10213Nature10213
Nature10213
Dickdick Maulana
 
Treating Clostridium Difficile Infection With Faecal Microbiota Transplantation
Treating Clostridium Difficile Infection With Faecal Microbiota TransplantationTreating Clostridium Difficile Infection With Faecal Microbiota Transplantation
Treating Clostridium Difficile Infection With Faecal Microbiota Transplantation
Edith Ngobi
 
Microbiota, leaky gut syndrome and gut-related diseases
Microbiota, leaky gut syndrome and gut-related diseasesMicrobiota, leaky gut syndrome and gut-related diseases
Microbiota, leaky gut syndrome and gut-related diseases
Maurizio Salamone
 
Impact of gut microbes on gastrointestinal disease
Impact of gut microbes on gastrointestinal diseaseImpact of gut microbes on gastrointestinal disease
Impact of gut microbes on gastrointestinal disease
Sandra Unorji
 
Interactions of the Immune System with the Gut Microbiome in Inflammatory Bo...
Interactions of the Immune System with the Gut Microbiome in Inflammatory Bo...Interactions of the Immune System with the Gut Microbiome in Inflammatory Bo...
Interactions of the Immune System with the Gut Microbiome in Inflammatory Bo...
Larry Smarr
 
Explore the cell's role in mediating adverse reactions
Explore the cell's role in mediating adverse reactionsExplore the cell's role in mediating adverse reactions
Explore the cell's role in mediating adverse reactions
Cell Science Systems
 
Experimental Biology 2016 Abstract
Experimental Biology 2016 AbstractExperimental Biology 2016 Abstract
Experimental Biology 2016 Abstract
Jon Lendrum
 
Biofilms
BiofilmsBiofilms
Poster Final Final Draft
Poster Final Final DraftPoster Final Final Draft
Poster Final Final Draft
Kara Lechtenberg
 
Antibiotic associated diarrhea
Antibiotic associated diarrheaAntibiotic associated diarrhea
Antibiotic associated diarrhea
Samir Haffar
 
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Vall d'Hebron Institute of Research (VHIR)
 
Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...
Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...
Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...
Larry Smarr
 
Asse fegato-intestino: quali le evidenze attuali? - Gastrolearning®
Asse fegato-intestino: quali le evidenze attuali? - Gastrolearning®Asse fegato-intestino: quali le evidenze attuali? - Gastrolearning®
Asse fegato-intestino: quali le evidenze attuali? - Gastrolearning®
Gastrolearning
 
Microbiota y la respuesta immune - Dra Romina Goldszmid
Microbiota y la respuesta immune - Dra Romina GoldszmidMicrobiota y la respuesta immune - Dra Romina Goldszmid
Microbiota y la respuesta immune - Dra Romina Goldszmid
Webee by Formar
 

What's hot (20)

Gut Reaction Synthesis 2015
Gut Reaction Synthesis 2015Gut Reaction Synthesis 2015
Gut Reaction Synthesis 2015
 
Charles poster_TK-1
Charles poster_TK-1Charles poster_TK-1
Charles poster_TK-1
 
Seminario biologia molecular
Seminario biologia molecularSeminario biologia molecular
Seminario biologia molecular
 
Statins Talk 2009
Statins Talk 2009Statins Talk 2009
Statins Talk 2009
 
The gut in critical Illness: A perspective in five acts by Prof. John Marshall
The gut in critical Illness: A perspective in five acts by Prof. John MarshallThe gut in critical Illness: A perspective in five acts by Prof. John Marshall
The gut in critical Illness: A perspective in five acts by Prof. John Marshall
 
BRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicine
BRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicineBRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicine
BRN Symposium 03/06/16 The respiratory microbiome: a new frontier in medicine
 
Nature10213
Nature10213Nature10213
Nature10213
 
Treating Clostridium Difficile Infection With Faecal Microbiota Transplantation
Treating Clostridium Difficile Infection With Faecal Microbiota TransplantationTreating Clostridium Difficile Infection With Faecal Microbiota Transplantation
Treating Clostridium Difficile Infection With Faecal Microbiota Transplantation
 
Microbiota, leaky gut syndrome and gut-related diseases
Microbiota, leaky gut syndrome and gut-related diseasesMicrobiota, leaky gut syndrome and gut-related diseases
Microbiota, leaky gut syndrome and gut-related diseases
 
Impact of gut microbes on gastrointestinal disease
Impact of gut microbes on gastrointestinal diseaseImpact of gut microbes on gastrointestinal disease
Impact of gut microbes on gastrointestinal disease
 
Interactions of the Immune System with the Gut Microbiome in Inflammatory Bo...
Interactions of the Immune System with the Gut Microbiome in Inflammatory Bo...Interactions of the Immune System with the Gut Microbiome in Inflammatory Bo...
Interactions of the Immune System with the Gut Microbiome in Inflammatory Bo...
 
Explore the cell's role in mediating adverse reactions
Explore the cell's role in mediating adverse reactionsExplore the cell's role in mediating adverse reactions
Explore the cell's role in mediating adverse reactions
 
Experimental Biology 2016 Abstract
Experimental Biology 2016 AbstractExperimental Biology 2016 Abstract
Experimental Biology 2016 Abstract
 
Biofilms
BiofilmsBiofilms
Biofilms
 
Poster Final Final Draft
Poster Final Final DraftPoster Final Final Draft
Poster Final Final Draft
 
Antibiotic associated diarrhea
Antibiotic associated diarrheaAntibiotic associated diarrhea
Antibiotic associated diarrhea
 
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
Gut microbiota for health: lessons of a metagenomic scan (by Joel Doré)
 
Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...
Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...
Tracking Large Variations in My Immune Biomarkers and My Gut Microbiome: Infl...
 
Asse fegato-intestino: quali le evidenze attuali? - Gastrolearning®
Asse fegato-intestino: quali le evidenze attuali? - Gastrolearning®Asse fegato-intestino: quali le evidenze attuali? - Gastrolearning®
Asse fegato-intestino: quali le evidenze attuali? - Gastrolearning®
 
Microbiota y la respuesta immune - Dra Romina Goldszmid
Microbiota y la respuesta immune - Dra Romina GoldszmidMicrobiota y la respuesta immune - Dra Romina Goldszmid
Microbiota y la respuesta immune - Dra Romina Goldszmid
 

Similar to Francisco Guarner Hospital Universitari Vall d'Hebron.

Dr. mohan microbiota chennai dec 4
Dr. mohan microbiota chennai dec 4Dr. mohan microbiota chennai dec 4
Dr. mohan microbiota chennai dec 4
neerjayakult
 
20180925 nutritionmeeting almere_lecture2
20180925 nutritionmeeting almere_lecture220180925 nutritionmeeting almere_lecture2
20180925 nutritionmeeting almere_lecture2
yakult1
 
probiotic symposium
 probiotic symposium probiotic symposium
probiotic symposium
ash2510
 
Probiotics final 2
Probiotics final 2Probiotics final 2
Probiotics final 2
neerjayakult
 
The_gut_joint_axis_in_rheumatoid_arthritis.pptx
The_gut_joint_axis_in_rheumatoid_arthritis.pptxThe_gut_joint_axis_in_rheumatoid_arthritis.pptx
The_gut_joint_axis_in_rheumatoid_arthritis.pptx
langgeng19
 
Microbiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ FawcettMicrobiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ Fawcett
Nicola Fawcett
 
Probiotics in Adult Gastroenterology
Probiotics in Adult GastroenterologyProbiotics in Adult Gastroenterology
Probiotics in Adult Gastroenterology
nutritionistrepublic
 
Human intestinal microbiome in health and diseases
Human intestinal microbiome in health and diseasesHuman intestinal microbiome in health and diseases
Human intestinal microbiome in health and diseases
arnab ghosh
 
Dr. neelam mohan
Dr. neelam mohanDr. neelam mohan
Dr. neelam mohan
neerjayakult
 
Human Gut Mycobiota
Human Gut MycobiotaHuman Gut Mycobiota
Human Gut Mycobiota
Maurizio Salamone
 
Safety assessment of probiotics for human use
Safety assessment of probiotics for human useSafety assessment of probiotics for human use
Safety assessment of probiotics for human use
Diwas Pradhan
 
H. pylori
H. pyloriH. pylori
H. pylori
Nasir Nazeer
 
Enfermedad inflamatoria intestinal
Enfermedad inflamatoria intestinal Enfermedad inflamatoria intestinal
Enfermedad inflamatoria intestinal
Carlos Pech Lugo
 
microbiata in medicine.pdf
microbiata in medicine.pdfmicrobiata in medicine.pdf
microbiata in medicine.pdf
mohieeldien elsayed
 
microbiata in medicine.pdf
microbiata in medicine.pdfmicrobiata in medicine.pdf
microbiata in medicine.pdf
mohieeldien elsayed
 
microbiata-----.pptx
microbiata-----.pptxmicrobiata-----.pptx
microbiata-----.pptx
ssuser13fc9c
 
Colon targeting
Colon targetingColon targeting
Colon targeting
Prachi Joshi
 
Wips
WipsWips
BRN Symposium 03/06/16 Lesson from the human gut microbiome
BRN Symposium 03/06/16 Lesson from the human gut microbiomeBRN Symposium 03/06/16 Lesson from the human gut microbiome
BRN Symposium 03/06/16 Lesson from the human gut microbiome
brnmomentum
 

Similar to Francisco Guarner Hospital Universitari Vall d'Hebron. (20)

Dr. mohan microbiota chennai dec 4
Dr. mohan microbiota chennai dec 4Dr. mohan microbiota chennai dec 4
Dr. mohan microbiota chennai dec 4
 
20180925 nutritionmeeting almere_lecture2
20180925 nutritionmeeting almere_lecture220180925 nutritionmeeting almere_lecture2
20180925 nutritionmeeting almere_lecture2
 
probiotic symposium
 probiotic symposium probiotic symposium
probiotic symposium
 
Probiotics final 2
Probiotics final 2Probiotics final 2
Probiotics final 2
 
The_gut_joint_axis_in_rheumatoid_arthritis.pptx
The_gut_joint_axis_in_rheumatoid_arthritis.pptxThe_gut_joint_axis_in_rheumatoid_arthritis.pptx
The_gut_joint_axis_in_rheumatoid_arthritis.pptx
 
Microbiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ FawcettMicrobiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ Fawcett
 
Probiotics in Adult Gastroenterology
Probiotics in Adult GastroenterologyProbiotics in Adult Gastroenterology
Probiotics in Adult Gastroenterology
 
Human intestinal microbiome in health and diseases
Human intestinal microbiome in health and diseasesHuman intestinal microbiome in health and diseases
Human intestinal microbiome in health and diseases
 
Dr. neelam mohan
Dr. neelam mohanDr. neelam mohan
Dr. neelam mohan
 
Human Gut Mycobiota
Human Gut MycobiotaHuman Gut Mycobiota
Human Gut Mycobiota
 
Safety assessment of probiotics for human use
Safety assessment of probiotics for human useSafety assessment of probiotics for human use
Safety assessment of probiotics for human use
 
H. pylori
H. pyloriH. pylori
H. pylori
 
Enfermedad inflamatoria intestinal
Enfermedad inflamatoria intestinal Enfermedad inflamatoria intestinal
Enfermedad inflamatoria intestinal
 
microbiata in medicine.pdf
microbiata in medicine.pdfmicrobiata in medicine.pdf
microbiata in medicine.pdf
 
microbiata in medicine.pdf
microbiata in medicine.pdfmicrobiata in medicine.pdf
microbiata in medicine.pdf
 
microbiata-----.pptx
microbiata-----.pptxmicrobiata-----.pptx
microbiata-----.pptx
 
Genetica bioinformatica
Genetica bioinformaticaGenetica bioinformatica
Genetica bioinformatica
 
Colon targeting
Colon targetingColon targeting
Colon targeting
 
Wips
WipsWips
Wips
 
BRN Symposium 03/06/16 Lesson from the human gut microbiome
BRN Symposium 03/06/16 Lesson from the human gut microbiomeBRN Symposium 03/06/16 Lesson from the human gut microbiome
BRN Symposium 03/06/16 Lesson from the human gut microbiome
 

More from Fundación Ramón Areces

Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Fundación Ramón Areces
 
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
Fundación Ramón Areces
 
Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London. Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London.
Fundación Ramón Areces
 
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Fundación Ramón Areces
 
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Fundación Ramón Areces
 
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI). Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Fundación Ramón Areces
 
Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.
Fundación Ramón Areces
 
Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School. Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School.
Fundación Ramón Areces
 
Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School. Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School.
Fundación Ramón Areces
 
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Unive...
Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Unive...Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Unive...
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Unive...
Fundación Ramón Areces
 
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
Fundación Ramón Areces
 
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Fundación Ramón Areces
 
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research. Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Fundación Ramón Areces
 
Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster. Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster.
Fundación Ramón Areces
 
Mercedes Ayuso - Universitat de Barcelona.
Mercedes Ayuso -  Universitat de Barcelona. Mercedes Ayuso -  Universitat de Barcelona.
Mercedes Ayuso - Universitat de Barcelona.
Fundación Ramón Areces
 
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics. Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Fundación Ramón Areces
 
Julia Campa - The Open University.
Julia Campa - The Open University. Julia Campa - The Open University.
Julia Campa - The Open University.
Fundación Ramón Areces
 
Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico. Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico.
Fundación Ramón Areces
 
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Fundación Ramón Areces
 
Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven. Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven.
Fundación Ramón Areces
 

More from Fundación Ramón Areces (20)

Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...
 
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...Dominique L. Monnet  Director del programa ARHAI (Antimicrobial Resistance an...
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...
 
Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London. Antonio Cabrales -University College of London.
Antonio Cabrales -University College of London.
 
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...
 
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...
 
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI). Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
Jonathan D. Ostry - Fondo Monetario Internacional (FMI).
 
Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.Martín Uribe - Universidad de Columbia.
Martín Uribe - Universidad de Columbia.
 
Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School. Thomas S. Robertson - The Wharton School.
Thomas S. Robertson - The Wharton School.
 
Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School. Diana Robertson - The Wharton School.
Diana Robertson - The Wharton School.
 
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Unive...
Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Unive...Juan Carlos López-Gutiérrez  - Unidad de Anomalías Vasculares, Hospital Unive...
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Unive...
 
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM).  I...
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...
 
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...
 
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research. Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research.
 
Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster. Diego Valero - Presidente del Grupo Novaster.
Diego Valero - Presidente del Grupo Novaster.
 
Mercedes Ayuso - Universitat de Barcelona.
Mercedes Ayuso -  Universitat de Barcelona. Mercedes Ayuso -  Universitat de Barcelona.
Mercedes Ayuso - Universitat de Barcelona.
 
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics. Nicholas Barr - Profesor de Economía Pública, London School of Economics.
Nicholas Barr - Profesor de Economía Pública, London School of Economics.
 
Julia Campa - The Open University.
Julia Campa - The Open University. Julia Campa - The Open University.
Julia Campa - The Open University.
 
Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico. Juan Manuel Sarasua - Comunicador y periodista científico.
Juan Manuel Sarasua - Comunicador y periodista científico.
 
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...
 
Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven. Frederic Lluis - Investigador principal en KU Leuven.
Frederic Lluis - Investigador principal en KU Leuven.
 

Recently uploaded

Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...
Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...
Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...
Sérgio Sacani
 
Summary Of transcription and Translation.pdf
Summary Of transcription and Translation.pdfSummary Of transcription and Translation.pdf
Summary Of transcription and Translation.pdf
vadgavevedant86
 
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
Scintica Instrumentation
 
Immunotherapy presentation from clinical immunology
Immunotherapy presentation from clinical immunologyImmunotherapy presentation from clinical immunology
Immunotherapy presentation from clinical immunology
VetriVel359477
 
Introduction_Ch_01_Biotech Biotechnology course .pptx
Introduction_Ch_01_Biotech Biotechnology course .pptxIntroduction_Ch_01_Biotech Biotechnology course .pptx
Introduction_Ch_01_Biotech Biotechnology course .pptx
QusayMaghayerh
 
Physiology of Nervous System presentation.pptx
Physiology of Nervous System presentation.pptxPhysiology of Nervous System presentation.pptx
Physiology of Nervous System presentation.pptx
fatima132662
 
BIRDS DIVERSITY OF SOOTEA BISWANATH ASSAM.ppt.pptx
BIRDS  DIVERSITY OF SOOTEA BISWANATH ASSAM.ppt.pptxBIRDS  DIVERSITY OF SOOTEA BISWANATH ASSAM.ppt.pptx
BIRDS DIVERSITY OF SOOTEA BISWANATH ASSAM.ppt.pptx
goluk9330
 
Microbiology of Central Nervous System INFECTIONS.pdf
Microbiology of Central Nervous System INFECTIONS.pdfMicrobiology of Central Nervous System INFECTIONS.pdf
Microbiology of Central Nervous System INFECTIONS.pdf
sammy700571
 
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptx
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptxTOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptx
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptx
shubhijain836
 
Sustainable Land Management - Climate Smart Agriculture
Sustainable Land Management - Climate Smart AgricultureSustainable Land Management - Climate Smart Agriculture
Sustainable Land Management - Climate Smart Agriculture
International Food Policy Research Institute- South Asia Office
 
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDS
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDSJAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDS
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDS
Sérgio Sacani
 
Direct Seeded Rice - Climate Smart Agriculture
Direct Seeded Rice - Climate Smart AgricultureDirect Seeded Rice - Climate Smart Agriculture
Direct Seeded Rice - Climate Smart Agriculture
International Food Policy Research Institute- South Asia Office
 
Reaching the age of Adolescence- Class 8
Reaching the age of Adolescence- Class 8Reaching the age of Adolescence- Class 8
Reaching the age of Adolescence- Class 8
abhinayakamasamudram
 
Holsinger, Bruce W. - Music, body and desire in medieval culture [2001].pdf
Holsinger, Bruce W. - Music, body and desire in medieval culture [2001].pdfHolsinger, Bruce W. - Music, body and desire in medieval culture [2001].pdf
Holsinger, Bruce W. - Music, body and desire in medieval culture [2001].pdf
frank0071
 
The cost of acquiring information by natural selection
The cost of acquiring information by natural selectionThe cost of acquiring information by natural selection
The cost of acquiring information by natural selection
Carl Bergstrom
 
Farming systems analysis: what have we learnt?.pptx
Farming systems analysis: what have we learnt?.pptxFarming systems analysis: what have we learnt?.pptx
Farming systems analysis: what have we learnt?.pptx
Frédéric Baudron
 
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
hozt8xgk
 
Flow chart.pdf LIFE SCIENCES CSIR UGC NET CONTENT
Flow chart.pdf  LIFE SCIENCES CSIR UGC NET CONTENTFlow chart.pdf  LIFE SCIENCES CSIR UGC NET CONTENT
Flow chart.pdf LIFE SCIENCES CSIR UGC NET CONTENT
savindersingh16
 
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆
Sérgio Sacani
 
Embracing Deep Variability For Reproducibility and Replicability
Embracing Deep Variability For Reproducibility and ReplicabilityEmbracing Deep Variability For Reproducibility and Replicability
Embracing Deep Variability For Reproducibility and Replicability
University of Rennes, INSA Rennes, Inria/IRISA, CNRS
 

Recently uploaded (20)

Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...
Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...
Evidence of Jet Activity from the Secondary Black Hole in the OJ 287 Binary S...
 
Summary Of transcription and Translation.pdf
Summary Of transcription and Translation.pdfSummary Of transcription and Translation.pdf
Summary Of transcription and Translation.pdf
 
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
(June 12, 2024) Webinar: Development of PET theranostics targeting the molecu...
 
Immunotherapy presentation from clinical immunology
Immunotherapy presentation from clinical immunologyImmunotherapy presentation from clinical immunology
Immunotherapy presentation from clinical immunology
 
Introduction_Ch_01_Biotech Biotechnology course .pptx
Introduction_Ch_01_Biotech Biotechnology course .pptxIntroduction_Ch_01_Biotech Biotechnology course .pptx
Introduction_Ch_01_Biotech Biotechnology course .pptx
 
Physiology of Nervous System presentation.pptx
Physiology of Nervous System presentation.pptxPhysiology of Nervous System presentation.pptx
Physiology of Nervous System presentation.pptx
 
BIRDS DIVERSITY OF SOOTEA BISWANATH ASSAM.ppt.pptx
BIRDS  DIVERSITY OF SOOTEA BISWANATH ASSAM.ppt.pptxBIRDS  DIVERSITY OF SOOTEA BISWANATH ASSAM.ppt.pptx
BIRDS DIVERSITY OF SOOTEA BISWANATH ASSAM.ppt.pptx
 
Microbiology of Central Nervous System INFECTIONS.pdf
Microbiology of Central Nervous System INFECTIONS.pdfMicrobiology of Central Nervous System INFECTIONS.pdf
Microbiology of Central Nervous System INFECTIONS.pdf
 
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptx
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptxTOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptx
TOPIC OF DISCUSSION: CENTRIFUGATION SLIDESHARE.pptx
 
Sustainable Land Management - Climate Smart Agriculture
Sustainable Land Management - Climate Smart AgricultureSustainable Land Management - Climate Smart Agriculture
Sustainable Land Management - Climate Smart Agriculture
 
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDS
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDSJAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDS
JAMES WEBB STUDY THE MASSIVE BLACK HOLE SEEDS
 
Direct Seeded Rice - Climate Smart Agriculture
Direct Seeded Rice - Climate Smart AgricultureDirect Seeded Rice - Climate Smart Agriculture
Direct Seeded Rice - Climate Smart Agriculture
 
Reaching the age of Adolescence- Class 8
Reaching the age of Adolescence- Class 8Reaching the age of Adolescence- Class 8
Reaching the age of Adolescence- Class 8
 
Holsinger, Bruce W. - Music, body and desire in medieval culture [2001].pdf
Holsinger, Bruce W. - Music, body and desire in medieval culture [2001].pdfHolsinger, Bruce W. - Music, body and desire in medieval culture [2001].pdf
Holsinger, Bruce W. - Music, body and desire in medieval culture [2001].pdf
 
The cost of acquiring information by natural selection
The cost of acquiring information by natural selectionThe cost of acquiring information by natural selection
The cost of acquiring information by natural selection
 
Farming systems analysis: what have we learnt?.pptx
Farming systems analysis: what have we learnt?.pptxFarming systems analysis: what have we learnt?.pptx
Farming systems analysis: what have we learnt?.pptx
 
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
 
Flow chart.pdf LIFE SCIENCES CSIR UGC NET CONTENT
Flow chart.pdf  LIFE SCIENCES CSIR UGC NET CONTENTFlow chart.pdf  LIFE SCIENCES CSIR UGC NET CONTENT
Flow chart.pdf LIFE SCIENCES CSIR UGC NET CONTENT
 
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆
SDSS1335+0728: The awakening of a ∼ 106M⊙ black hole⋆
 
Embracing Deep Variability For Reproducibility and Replicability
Embracing Deep Variability For Reproducibility and ReplicabilityEmbracing Deep Variability For Reproducibility and Replicability
Embracing Deep Variability For Reproducibility and Replicability
 

Francisco Guarner Hospital Universitari Vall d'Hebron.

  • 1. Jornada de Microbiota Intestinal Implicaciones en la Salud y Enfermedad Madrid, 23 de octubre de 2017
  • 2. Guarner & Malagelada, Lancet 2003
  • 3. http://www.hmdb.ca Fluid Total Microbial origin % Microbial origin All fluids 3821 129 3,4 Blood 2273 102 4,5 Urine 1741 101 5,8 Saliva 1233 59 4,8 CSF 440 36 8,2 Number of Metabolites Detected in Human Fluids
  • 4. ILEO-CECAL DYSBIOSIS IN CHRONIC LIVER DISEASE Guarner C & Runyon BA. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997 Pardo A, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 2000 Francés R, et al. Bacterial translocation is downregulated by anti-TNF-alpha monoclonal antibody administration in rats with cirrhosis and ascites. J Hepatol 2007
  • 5. SERUM MICROBIOME IN CHRONIC LIVER DISEASE Santiago et al. Scientific Reports 2016
  • 6. MICROBIOTA-INDUCED PROGRESSION TO CHRONIC LIVER DISEASE Schnabl & Brenner, Gastroenterology 2015
  • 7. Decision making in the adaptive (acquired) immune system is instructed by the microbial impact on APCs and T cells CD4 TCR APC CD4 Th1, Th17 Treg Foxp3+ Th2 TNF-, IFN- IL-17 IL-10 IL-4, IL-5, IL-13 CD4 CD4 + – – – – PRR Foreign antigen (Ag) Naive T-cell activation Cytokines + TGF-b Signatures via pattern recognition receptors (PRRs): TLRs & NLRs (NOD+LRR) Ligation MHC II T + By Per Brandtzaeg in Guarner et al, Nature Clin Practice 2006
  • 8. F F FAE Gut-Associated Lymphoid Tissue structures are strategically situated in relation to the greatest concentration of microbiota • Peyer’s patches: distal ileum (nos. 100-250) • Isolated lymphoid follicles (ILFs): large bowel (nos. ~ 30 000) Brandtzaeg, Immunological Investigations 2010
  • 9. HUMAN BLOOD REGULATORY CELLS INDUCED BY Faecalibacterium prausnitzii Sarrabayrouse et al, PLoS Biol 2014
  • 10. Commensal microbiota affects ischemic stroke outcome Benakis et al, Nat Med 2016
  • 11. Anticancer Immunotherapy and Microbiota Vetizou et al, Science 2015
  • 12. Anticancer immunotherapy and microbiota Vetizou et al, Science 2015
  • 13. THE ENEMY IS WITHIN THE FAECAL STREAM Rutgeerts P, Goboes K, Peeters M, Hiele M, Penninckx F, Aerts R, Kerremans R, Vantrappen G. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991;338:771-4. Winslet MC, Allan A, Poxon V, Youngs D, Keighley MR. Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the inflammatory process. Gut 1994;35:236-42. D’Haens GR, Geboes K, Peeters M, Baert F, Penninckx F, Rutgeerts P. Early lesions of recurrent Crohn’s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 1998;114:262–267.
  • 15. Adapted from Holtmann et al. Z Gastroenterol 2002 Cell detachment Macrophage TNF- TNF- Severe tissue injury by inflammation: role of TNF- enderetal,JImmunol1998
  • 16. Modern life style Traditional lifestye Birth in the hospital; increasing rate of caesarean delivery Vaginal delivery at home Small family size Large family size, crowding Life on concrete Life in contact with soil microorganisms Sanitation of living spaces: environment colonized by resistant micro-organisms (including resistant bacteria, fungii, acari) Ancestral colonization of the living environment Antibiotic usage early in life No antibiotics in infant life Daily body wash with hot water and soap Limited access to hot water and soap Low rate of H. pylori colonization High rate of H. pylori colonization Decline in endemic parasitism Common carriage of parasitic worms Food conserved by refrigeration Food conserved by microbial fermentation Consumption of processed foods Consumption of natural foods IBD risk factors are linked with altered microbial colonization Manichanh et al, Nature Reviews Gastroenterology 2012
  • 17. Blaser & Falkow, Nature Rev Microbiol 2009
  • 18. Clemente et al, Science Advances 2015
  • 19. Clemente et al, Science Advances 2015
  • 20. Manichanh et al, Nat Rev GH 2012 Profiling the Human Microbiome
  • 21. Dysbiosis in IBD Pascal et al, Gut 2017
  • 22. Meta-Genomic Species Nielsen et al, Nature Biotechnology 2014
  • 23. Gene Richness and Species Diversity Nielsen et al, Nature Biotechnology 2014
  • 24. • Richness is greatly altered in Crohn’s Disease •* • * •Gene Count •Species count •Genes,N° •MGS,N° •050000010000001500000 •0100200300400 500 •p = 4.3e-10 (wilcox. test) • p = 4.9e-9 (wilcox. test) •Healthy, n = 52 •CD, n = 73 •Healthy, n = 52 •CD, n = 73 •24
  • 25. Richness is less altered in Ulcerative Colitis * MGS,N° Genes,N° p = 0.15 (wilcox. test) Gene Count Species count p = 0.019 (wilcox. test) Healthy, n = 56 Healthy, n = 56UC, n = 65 UC, n = 65 2000006000001000000 100200300400500 •25Maziers et al, IHMC 2016
  • 26. •26 Strong Species signal in CD Healthy, n = 52 CD, n = 73 Healthy CD Richness Numerous Faecalibacterium spp Maziers et al, IHMC 2016
  • 27. Less strong Species signal associated with UC Healthy, n = 28 HR, n = 28 UC -1, n = 34 UC-2, n = 31 Healthy UC Richness •27 Maziers et al, IHMC 2016
  • 28. • Reduction of SCFA producing bacteria (butyrate producers such as Faecalibacterium, Roseburia, Lachnospiraceae, Eubacterium, Subdoligranulum). • Increased mucus degradation potential by abnormal mucin degraders that displace Akkermansia. • Reduced hydrogen and methane production potential combined with increased hydrogen sulphide formation potential. Hydrogen sulphide is toxic for the epithelium. • Increase in abundance of bacteria with LPS endotoxins (Proteobacteria) that can drive inflammation. • Increased potential to manage oxidative stress, i.e. microbes become able to proliferate in close vicinity to the epithelium.
  • 29. Conclusiones • En pacientes con EII, hay una distorsión permanente del ecosistema microbiano intestinal, incluso durante períodos de remisión, caracterizada por reducción de riqueza de genes microbianos, reducción de la diversidad de especies e inestabilidad de la comunidad. • CD y UC tienen firmas microbianas distintas a nivel taxonómico, pero las alteraciones funcionales son parecidas. • Los cambios son más intensos en pacientes con CD, mientras que los pacientes UC presentan mejor recuperación durante los períodos de remisión.
  • 30. Acknowledgments MetaHIT Consortium HUVH: V. Robles, N. Borruel, F. Casellas, F. Guarner INRA: E. Le Chatelier, N. Maziers, D. Ehrlich La Fe (Valencia) : B. Beltrán, P. Nos Parc Tauli (Sabadell) : A. Villoria, X. Calvet